Prognostic value of myocardial scar in ischaemic and non-ischaemic cardiomyopathy using cardiac magnetic resonance imaging

被引:1
|
作者
Laymouna, Reem [1 ,2 ]
El-Sharkawy, Eman [1 ,2 ]
El-Taha, Salah [1 ,2 ]
Elfiky, Mohamed [1 ]
机构
[1] Alexandria Univ, Cardiol & Angiol Dept, Alexandria, Egypt
[2] Int Cardiac Ctr Scan, Alexandria, Egypt
关键词
ischaemic cardiomyopathy; non-ischaemic cardiomyopathy; cardiac MRI; myocardial scar; LATE GADOLINIUM ENHANCEMENT; DILATED CARDIOMYOPATHY; QUANTIFICATION; PREDICTION; MRI;
D O I
10.5830/CVJA-2022-040
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: The aim of this research was to evaluate the prognostic value of myocardial scar using cardiac magnetic resonance (CMR) imaging in patients with ischaemic cardiomyopathy (ICM) and non-ischaemic cardiomyopathy (NICM).Methods: One hundred and fifty-four patients with either ICM or NICM underwent CMR with late gadolinium enhancement sequences for assessment of left ventricular ejection fraction (LVEF), and detection and quantification of any myocardial scar using three methods: manual, number of segments involved, and percentage of scarred myocardium. Patients were followed up for at least six months for clinical cardiac events.Results: Patients were divided into two groups: group I, patients with ICM (58%) and group II, those with NICM (42%). Clinical presentation ranged from eventless (10%) to chest pain (18%), heart failure (15%), hospitalisation (35%), syncope (1%), ventricular tachycardia (< 1%) and cardiac arrest (< 1%). The scar mass was larger in size in group I (17 +/- 15%) than in group II (8 +/- 13%). A direct relationship was observed between scar size and event severity (p < 0.001). An inverse relationship between LVEF and event severity was found in group I (p < 0.001) but not in group II (p = 0.128).Conclusion: Myocardial scar size was a strong predictor of clinical outcome in both the ICM and NICM patients. LVEF was less reliable in predicting morbidity in cardiomyopathy patients.
引用
收藏
页码:132 / 139
页数:8
相关论文
共 50 条
  • [41] Renal function in ischaemic and non-ischaemic cardiomyopathy: effects on survival and neurohormones
    Smilde, TDJ
    Hillege, HL
    Navis, G
    Van Veldhuisen, DJ
    EUROPEAN HEART JOURNAL, 2003, 24 : 188 - 188
  • [42] The role of carotid atherosclerosis in the distinction between ischaemic and non-ischaemic cardiomyopathy
    Androulakis, AE
    Andrikopoulos, GK
    Richter, DJ
    Tentolouris, CA
    Avgeropoulou, CC
    Adamopoulos, DA
    Toutouzas, PK
    Trikas, AG
    Stefanadis, CI
    Gialafos, JE
    EUROPEAN HEART JOURNAL, 2000, 21 (11) : 919 - 926
  • [43] PREVALENCE AND PREDICTORS OF MYOCARDIAL RECOVERY IN NON-ISCHAEMIC CARDIOMYOPATHY: A SYSTEMATIC REVIEW
    Barton, Anna
    Docherty, Kieran
    Campbell, Ross
    Simpson, Joanne
    Dalzell, Jonathan
    Gardner, Roy
    Petrie, Mark
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 843 - 843
  • [44] Risk Stratification for Sudden Cardiac Death in Non-Ischaemic Dilated Cardiomyopathy
    Akhtar, M.
    Elliott, P. M.
    CURRENT CARDIOLOGY REPORTS, 2019, 21 (12)
  • [45] Cochrane corner: implantable cardiac defibrillators for patients with non-ischaemic cardiomyopathy
    El Moheb, Mohamad
    Nicolas, Johny
    Khamis, Assem
    Akl, Elie A.
    Refaat, Marwan M.
    HEART, 2020, 106 (09) : 636 - 638
  • [46] Risk Stratification for Sudden Cardiac Death in Non-Ischaemic Dilated Cardiomyopathy
    M. Akhtar
    P. M. Elliott
    Current Cardiology Reports, 2019, 21
  • [47] Is there such as a thing as non-ischaemic cardiac pain?
    Zareifopoulos, Nicholas
    HEART ASIA, 2016, 8 (02) : 54 - 55
  • [48] Heart failure in dilated non-ischaemic cardiomyopathy
    Seferovic, Petar M.
    Polovina, Marija M.
    Coats, Andrew J. S.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0M) : M40 - M43
  • [50] Cardiovascular Magnetic Resonance Imaging of Non-ischaemic Heart Disease: Established and Emerging Applications
    Bohl, Steffen
    Schulz-Menger, Jeanette
    HEART LUNG AND CIRCULATION, 2010, 19 (03): : 117 - 132